Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ)

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) — VMCI valuation read

Composite valuation read on 002864.SZ: VMCI 58/100 against a Healthcare sector median of 50. The 8-point above-median print is the headline number for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd, and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for 002864.SZ: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on 002864.SZ: 002864.SZ trades at 19.0x earnings, 6% above the Healthcare median of 18.0x; ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%); net debt to EBITDA of -1.2x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

002864.SZ fell 1.2% over the trailing 7 days, with a -15.5% read on a 30-day basis.